2Hagemeister F. Rituximab for the treatment of non-hodgkin's lymphoma and chronie lymphoeytic leukaemia[ J ]. Drugs,2010 ;70 ( 3 ) :261-72.
3Morton LM, Gurtis RE, Linet MS, et al. Second malignancy risks after non- Hodgkin's lymphoma and chronic lymphocytic leukemia differences by lymphoma subtype[J]. J Glin Onco1,2010 ;28 (33) :4935-44.
4Nicholson ML, Kaushik M, Lewis GR, et al. Randomized clinical trial of laparospic versus open donor nephrectomy[J] Br J Surg, 2010;97 ( I ) : 21-8.
5Laurent C,Leblanc F,Wutrich P,et al.Laparoscopic versusopen surgery for rectal cancer: long-term oncologic results[J].Ann Surg,2009,250(1):54-61.
6Faerden AE, Naimy N, Wiik P, et al. Total mesorectalexcision for rectal cancer:difference in outcome for low andhigh rectal cancer[J]. Dis Colon Rectum,2005,48(12):2224-2231.
8Dulucq JL, Wintringer P, Stabilini C, et al. Laparoscopicrectal resection with anal sphincter preservation for rectalcancer:long term outcome[J].Surg Endosc,2005,19(11):1468-1474.
9Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Reserch Council CLASICC trial of laparo-scopically assisted versus open surgery for colorecteal cancer[J]. Br J surg, 2010, 97(11):1638-1645.
10Law WL,Poon JT,Fan JK,et al.Comparison of outcome ofopen and laparoscopic resection for stage Ⅱ? and stageⅢ? rectal cancer [ J]. Ann Surg Oncol,2009,16 ( 6):1488-1493.
